What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Do-Hyun Nam mainly focuses on Cancer research, Stem cell, Glioma, Cancer and Cancer cell.
In the subject of general Cancer research, his work in Temozolomide is often linked to Somatic hypermutation, thereby combining diverse domains of study.
His study in Stem cell is interdisciplinary in nature, drawing from both Wnt signaling pathway, Signal transduction, Transplantation and Pathology.
Do-Hyun Nam combines subjects such as Radioresistance, Isocitrate dehydrogenase and Kinase with his study of Glioma.
His Cancer research is multidisciplinary, relying on both Radiosurgery, Glioblastoma, Confidence interval and Gene expression profiling.
His research integrates issues of Cell and In vivo in his study of Cancer cell.
His most cited work include:
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (523 citations)
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma (515 citations)
- Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. (499 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Surgery, Internal medicine, Cancer and Pathology.
His work carried out in the field of Cancer research brings together such families of science as Cancer cell, Metastasis and Stem cell.
As a part of the same scientific family, Do-Hyun Nam mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Glioblastoma.
His Cancer study incorporates themes from Brain tumor and Bioinformatics.
Do-Hyun Nam regularly ties together related areas like Brain metastasis in his Pathology studies.
His research investigates the link between Angiogenesis and topics such as In vivo that cross with problems in Pharmacology.
He most often published in these fields:
- Cancer research (51.80%)
- Surgery (18.47%)
- Internal medicine (17.62%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (51.80%)
- Glioblastoma (13.38%)
- Glioma (16.35%)
In recent papers he was focusing on the following fields of study:
Do-Hyun Nam mainly investigates Cancer research, Glioblastoma, Glioma, Internal medicine and Cancer.
His biological study spans a wide range of topics, including Cancer cell, Phenotype, Metastasis and Stem cell.
Do-Hyun Nam interconnects T lymphocyte, CD8, Magnetic resonance imaging, Epitope and Immunotherapy in the investigation of issues within Glioblastoma.
His work on Temozolomide as part of general Glioma research is frequently linked to Somatic hypermutation, thereby connecting diverse disciplines of science.
In his study, Survival rate and Transcriptome is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
His Cancer research is multidisciplinary, incorporating perspectives in Viability assay and Drug.
Between 2017 and 2021, his most popular works were:
- Longitudinal molecular trajectories of diffuse glioma in adults (92 citations)
- Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. (84 citations)
- Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. (84 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Cancer research, Glioma, Glioblastoma, Cancer cell and Tumor microenvironment.
His Cancer research study combines topics from a wide range of disciplines, such as Carcinogenesis, Cancer, Transcriptome, Stem cell and ATRX.
His research in Glioma intersects with topics in Brain tumor, Germline mutation and Secondary Glioblastoma, IDH1.
His work deals with themes such as Glycocalyx, Glycoprotein, Integrin, Magnetic resonance imaging and Extracellular matrix, which intersect with Glioblastoma.
His Cancer cell research is multidisciplinary, incorporating elements of Cell, Gene expression, Transactivation and Signal transduction, Cell biology.
As a part of the same scientific study, he usually deals with the Temozolomide, concentrating on Regulation of gene expression and frequently concerns with Oncology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
